Highlights
NASDAQ: BGNE       Beigene Ltd ADR
Last Price Today's Change   Day's Range   Trading Volume
403.14   +17.90 (4.65%)  395.00 - 426.56  1,364,100

Overview

 
Avg Volume (4 weeks):456,902
4 Weeks Range:238.88 - 426.56
4 Weeks Price Volatility (%):
87.52%
52 Weeks Range:219.20 - 426.56
52 Weeks Price Volatility (%):
88.71%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

BeiGene Ltd is a United States based clinical-stage biopharmaceutical company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. It has developed clinical-stage drug candidates that inhibit the important oncology targets Bruton's tyrosine kinase, or BTK; RAF dimer protein complex and PARP family of proteins, and an immuno-oncology agent that inhibits the immune checkpoint protein receptor PD-1.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

4031  5720  849  583 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CRVS 5.32+3.06 
 PLTR 28.71+0.08 
 CEI 1.69-0.03 
 SDC 6.70+0.70 
 AAPL 146.06-2.73 
 SPY 441.40-5.77 
 SQQQ 7.68+0.26 
 FAMI 0.227-0.013 
 LCID 22.96+1.79 
 BAC 40.50+0.05